BLUEBIRD BIO INC (BLUE) Stock Income Statement
NASDAQ:BLUE - Nasdaq - US09609G2093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 103.95M | 83.81M | 29.50M | 3.60M | 3.66M | |||
| Cost Of Goods | 75.75M | 89.38M | 33.53M | 10.08M | 38.86M | |||
| Gross Profit | 28.19M | -5.57M | -4.03M | -6.48M | -35.20M | |||
| Operating Expenses | 238.71M | 262.13M | 333.16M | 377.67M | 529.91M | |||
| Research and Development | 86.90M | 94.25M | 167.65M | 240.76M | 319.95M | |||
| Selling, General, and Administrative Expenses | 151.81M | 167.87M | 165.51M | 136.91M | 209.97M | |||
| Operating Income | -210.51M | -267.70M | -337.19M | -384.15M | -565.11M | |||
| Interest Income/Expense | -16.43M | -14.36M | -6.48M | -2.07M | 30.28M | |||
| Other Income/Expense | 32.99M | 44.18M | 38.71M | 22.70M | -1.75M | |||
| Non Recurring Items | -5.86M | -2.76M | 92.93M | 97.06M | -25.80M | |||
| Income Before Taxes | -199.81M | -240.65M | -212.04M | -266.46M | -562.38M | |||
| Income Tax | 170.00K | 70.00K | -126.00K | 120.00K | 260.00K | |||
| Net Income | -199.98M | -240.72M | -211.91M | -266.58M | -819.38M | |||
| EBITDA | -149.20M | -206.46M | -308.67M | -379.15M | -545.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -20.61 | -24.84 | -38.59 | -3.39 | -11.89 | |||
| Non GAAP EPS | -20.53 | -24.75 | N/A | -4.68 | -11.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | 27.12% | -6.65% | -13.66% | -180.00% | -961.75% | |||
| Profit Margin | -192.39% | -287.23% | -718.42% | -7405.00% | -22387.43% | |||
| Operating Profit Margin | -202.52% | -319.42% | -1143.14% | -10670.83% | -15440.16% | |||
All data in USD